Global Meningococcal Vaccines Market was valued at USD xx million in 2018 and is expected to reach at USD xx million by 2026 at a CAGR of xx% over forecast period 2019-2026.Global Meningococcal Vaccines Market by End UsersMeningococcal vaccines are used to treat meningitis caused by bacterium N. meningitides. The major factors for the growth of the meningococcal vaccines market include an increase in public-private partnerships to support the development of vaccines at low cost, and rising immunization programs and government initiatives. Increasing awareness level of diseases and their vaccines also drives the market for meningococcal vaccines over forecast period.
World Health Organization is promoting strategies for prevention of meningitis and is hoping to introduce this vaccine in a moderate or high rate of disease countries of African region, which are suffering from meningitis and they hope to achieve. This would provide growth opportunities in this market.
However, the maintenance of cold chain for the delivery of vaccines leads to rise in cost of vaccination, is expected to restrain the market growth.Global Meningococcal Vaccines Market is segmented by types, by end users and by region. By types market is segmented into various vaccines such as bivalent, quadrivalent, Serogroup A, Serogroup B, and Serotype X. Quadrivalent segment is expected to exhibit highest market share at a CAGR of xx% over forecast period owing to the presence of high unmet needs and lack of availability of alternate vaccines.
Various brands such as Mentactra, Menveo, Trumenba and Mentlibrix and Menoveo are available in the market for the treatment of meningococcal. By geography, Global Meningococcal Vaccines Market is segmented into APAC, North America, Europe, MEA& Africa and Latin America. North America is expected to lead the global meningococcal market thanks to an increasing government interventions and prevention programs, research and development initiatives by various manufacturers. In Canada and the United States the vaccines effective against all four types of meningococcus are recommended routinely for teenagers and others who are at high risk.Moreover, Asia-Pacific is expected to be the fastest growing market due to low manufacturing cost and increasing healthcare spending.
Key players operating in this market are Neuron Biotech, Baxter international, Pfizer Inc., Novartis International, Sanofi S.A., JN-International Medical Corporation, Biomed Pvt. Ltd., and Serum Institute of India Ltd. These key players are using various organic and inorganic growth strategies such as merger and acquisition, expansion, strategic alliances, new product launches, research and development to enhance their business operations and regional presence.
The objective of the report is to present a complete calculation of the Global Meningococcal Vaccines Market and contains thoughtful insights, historical data, facts, industry-validated market data and plans with a suitable set of assumptions and methodology. The report also helps in the Global Meningococcal Vaccines Market is a dynamic structure by identifying and analyzing the market segments and project the global market size. The additional, report also focuses on the competitive analysis of key player’s by-product, financial position, price, product portfolio, growth strategies, and regional presence. The report also provides PEST analysis, PORTER’s analysis, and SWOT analysis to address the question of shareholders to prioritizing the efforts and investment shortly to the emerging segment in the Global Meningococcal Vaccines Market.
Scope of Global Meningococcal Vaccines Market
Global Meningococcal Vaccines Market by Types
• Quadrivalent vaccines
• Bivalent vaccines
• Serogroup A
• Serogroup B
• Serogroup X
Global Meningococcal Vaccines Market by Geography
• North America
• Latin America
• MEA& Africa
Global Meningococcal Vaccines Market by End Users
• Preteens or Teens
Global Meningococcal Vaccines Market Major players
• Neuron Biotech
• Baxter international
• Pfizer Inc.
• Novartis International
• Sanofi S.A.
• JN-International Medical Corporation
• Biomed Pvt. Ltd.
• Serum Institute of India Ltd.
• GlaxoSmithKline plc.
• Neuron Biotech
For More Information Visit @:https://www.maximizemarketresearch.com/market-report/global-meningococcal-vaccines-market/39058/
This Report Is Submitted By : Maximize Market Research Company
Customization of the report:
Maximize Market Research provides free personalized of reports as per your demand. This report can be personalized to meet your requirements. Get in touch with us and our sales team will guarantee provide you to get a report that suits your necessities.
About Maximize Market Research:
Maximize Market Research provides B2B and B2C research on 20,000 high growth emerging opportunities & technologies as well as threats to the companies across the Healthcare, Pharmaceuticals, Electronics & Communications, Internet of Things, Food and Beverages, Aerospace and Defense and other manufacturing sectors.
Name: Lumawant Godage
Organization Address: MAXIMIZE MARKET RESEARCH PVT. LTD.
Address: Pune, Maharashtra 411051, India.